Lentz RW, Friedrich TJ, Blatchford PJ, Jordan KR, et al. A phase II study of potentiation of pembrolizumab with binimetinib and bevacizumab in refractory microsatellite stable colorectal cancer. Clin Cancer Res 2024 Jun 13. doi: 10.1158/1078-0432.CCR-24-0090.
PMID: 38869830